Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001822629-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-17 | 2026-02-12+ | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $77.01 | -22.0K | 358.6K | -6% | -$1.69M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | F | D | 11,688 | $76.70 | 368,872 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-14 | F | D | 10,298 | $77.36 | 358,574 | D | — | — |